David C. Whitcomb, MD, PhD is the Professor of Medicine, Cell Biology, and Physiology at the University of Pittsburgh and Chief of Gastroenterology, Hepatology & Nutrition for University of Pittsburgh Medical Center (UPMC). Dr. Whitcomb founded the Center for Genomic Sciences (now part of the Genomics and Proteomics Core Laboratory), served as Director of the Nutrition Support Service and Director of Gastroenterology for the Pittsburgh VA Healthcare System. He is the Giant Eagle Foundation Professor of Cancer Genetics and Medical Director of the UPMC Liver-Pancreas Institute Comprehensive Pancreas Program. Dr. Whitcomb is a member of many professional and scientific societies, serving as president of the American Pancreatic Association, Chairman of the Pancreatic Disorders Section of the American Gastroenterology Association and serves on the National Pancreas Foundation board of directors. Dr. Whitcomb founded and leads the Midwest Multicenter Pancreatic Study Group, the Collaborative Alliance for Pancreatic Education and Research (CAPER), and started and sponsors PancreasFest, an annual international translational meeting every July in Pittsburgh. Dr. Whitcomb has written over 200 scientific articles and edited 8 books.
Dr. Mark Haupt, MD is the Chief Medical Officer of Ariel Precision Medicine, an integrated genomics and digital health company delivering precision medicine solutions for the diagnosis, monitoring and treatment of complex chronic diseases and disorders such as pancreatitis. Dr. Haupt was previously with AbbVie Pharmaceuticals, quickly accelerating from their Physician Professional Development Program to a leadership role in the US Medical Affairs organization and earning the President’s Award. He completed a residency in general pediatrics at the University of Chicago Medical Center, earning intern and resident of the year awards. After serving an additional year as Chief Resident, Dr. Haupt completed a fellowship in Pediatric Pulmonary Medicine at the Ann & Robert H.Lurie Children’s Hospital of Chicago. His research focus was cystic fibrosis, specifically examining epidemiological data to evaluate nutritional outcomes.